Peripheral Arterial Disease Patients’ awareness of smoking as a risk factor Class 5, 1 st year 2009/2010 Adviser: Sérgio Sampaio.

Slides:



Advertisements
Similar presentations
Physical Activity Promotion Project in asthmatic children and adolescents Amélia Fernandes Belarmino João José Carlos Gomes Sérgio Fernandes Context: Asthma.
Advertisements

How would you explain the smoking paradox. Smokers fair better after an infarction in hospital than non-smokers. This apparently disagrees with the view.
PAD Rehabilitation Toolkit A Guide for Healthcare Professionals Healthy Steps for Peripheral Artery Disease (PAD) Developed by AACVPR and the Vascular.
A Call for Partnerships Between Adult Literacy, Public Health, and Medicine Dean Schillinger, MD UCSF Associate Professor of Medicine Community Engagement.
JAMES R. CHRISTINA, DPM DIRECTOR SCIENTIFIC AFFAIRS AMERICAN PODIATRIC MEDICAL ASSOCIATION FOOTCARE AND DIABETES.
Epidemiology of Peripheral Vascular Disease Sohail Ahmed School of Population and Health Sciences.
Biostatistics - Concepts Tudor Calinici – JPEMS 2014.
PAD A Call to Action. PAD: A Call to Action - What is peripheral arterial disease (PAD)? and why is it so dangerous? - Diagnosing PAD in the primary care.
The efficacy evaluation of interventions with tobacco’s consumers: an action that modifies the discursive configuration Dalila Barbanera and Eleonora Pinto.
Biostatistics ~ Types of Studies. Research classifications Observational vs. Experimental Observational – researcher collects info on attributes or measurements.
Drug Hypersensitivity Prevalence in the Adult Population Group 13 Medical Faculty of University of Porto Medical Faculty of University of Porto Introduction.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May-June 2008.
Type 2 diabetes and high blood pressure How explosive is the cocktail?
Uncontrolled Hypertension, Systolic and Diastolic Blood Pressure and Development of Symptomatic Peripheral Arterial Disease in the Women’s Health Study.
Stay in Circulation Facts About Peripheral Arterial Disease (P.A.D.) A National Public Awareness Campaign from the P.A.D. Coalition and the National Heart,
Presented by Michelle Sitto. The term peripheral vascular disease is commonly used to refer to peripheral artery disease (PAD), meaning narrowing or occlusion.
Overly concerning and falsely reassuring?? FRAMINGHAM RISK FACTORS IN THE ED.
C-Reactive Protein: a Prognosis Factor for Septic Patients Systematic Review and Meta-analysis Introduction to Medicine – 1 st Semester Class 4, First.
Biology in Focus, HSC Course Glenda Childrawi, Margaret Robson and Stephanie Hollis A Search For Better Health Topic 11: Epidemiology.
Hemoglobin A 1c in Hemodialysis Patients Source: Ix JH. Hemoglobin A1c in hemodialysis patients: Should one size fit all? Clin J Am Soc Nephrol. 2010;5:1539–1541.
{ R. Diaz-Garcia MD, J. Bernardo MD Stem Cell Therapy for Patients with Critical Limb Ischemia: A Meta-analysis with Critical Limb Ischemia: A Meta-analysis.
Identifying the Presence of Peripheral Artery Disease in Patients With and Without Diabetes Lori Brown, PharmD and Charles Herring, PharmD, BCPS, CPP University.
Special Report Peripheral Arterial Disease: Lack of Awareness in Canada The First Canadian P.A.D. Public Awareness Survey Peripheral Arterial Disease:
AN ASSESSMENT OF THE PRIMARY PREVENTION CONTROL PROGRAM OF PHC PREVENTIVE CARDIOLOGY CLINIC AMONG PATIENTS AT RISK FOR CVD: A Retrospective Cohort Study.
The potential impact of adherence to a guideline on the utilization of head CT scans in traumatic head injury patients. Frederick K. Korley M.D.
Peripheral Arterial Disease Patients’ awareness of smoking as a risk factor Class 5, 1 st year 2009/2010 Adviser: Sérgio Sampaio.
PREVALENCE OF RISK FACTORS FOR DIABETIC FOOT ULCER AND RISK STRATIFICATION IN TYPE 2 DIABETES DR. NEETA DESHPANDE ASSOCIATE PROF.,JN MEDICAL COLLEGE AND.
Self-reported cognitive and emotional effects and lifestyle changes shortly after preventive cardiovascular consultations in general practice Dea Kehler.
دکتر خلیلی 1. Lucid the way to “ Research” And Follow an “ Evidence Based Medicine”
Evaluating. Evaluation the nurse and the patient together measure how well the patient has achieved the outcomes specified in the plan of care allow the.
Peripheral Arterial Disease Patients’ awareness of smoking as a risk factor Class 5, 1 st year 2009/2010 Adviser: Sérgio Sampaio.
André Maia Bárbara Moura David João Inês Machado José Silva Liliana Costa Márcio Mesquita Maria Inês Rocha Isabel Rodrigues Pedro Nóvoa Rui Silva Sara.
ALI R. RAHIMI, BOBBY WRIGHTS, MD, HOSSEIN AKHONDI, MD & CHRISTIAN M. RICHARD, MSC Clinical Correlation Between Effective Anticoagulants & Risk of Stroke:
Community Outreach to Reduce Disparities in Cardiovascular & Diabetes Morbidity & Mortality in the South Bronx Michael Alderman, MD Michelle Johnson, MD,
CLINICAL AUDIT A quick guide. Why Audit? ‘Clinical audit is about improvement. If you are not changing or improving things as a result of audit then ask.
Margot E. Ackermann, Ph.D. and Erika Jones-Haskins, MSW Homeward  1125 Commerce Rd.  Richmond, VA Acknowledgements The Richmond.
1 Impact of Implementing Designed Nursing Intervention Protocol on Clinical Outcome of Patient with Peptic Ulcer By Amal Mohamed Ahmad Assistant Professor,
Peripheral Arterial Disease Doctor’s Name Contact Information.
CROSS SECTIONAL STUDIES
Medical Management of Claudication: Just Walk it Off!!
1 CONFIDENTIAL – DO NOT DISTRIBUTE ARIES mCRC: Effectiveness and Safety of 1st- and 2nd-line Bevacizumab Treatment in Elderly Patients Mark Kozloff, MD.
CASE CONTROL STUDY. Learning Objectives Identify the principles of case control design State the advantages and limitations of case control study Calculate.
S1207: Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients.
 Major concepts  Focused on key issues for practice, education, and administration  Examples: chronic pain, acute pain, self-care, coping, health.
Blood pressure control: Where do we stand? Latest data from Italy Tocci G et al. J Hypertens. 2012;30:
Dr. Nadira Mehriban. INTRODUCTION Diabetic retinopathy (DR) is one of the major micro vascular complications of diabetes and most significant cause of.
Purpose Methods Results Conclusions The aim was to determine the annual rate of cardiovascular events in an outpatient population with established cardiovascular.
Peripheral Artery Disease in Orthopaedic Patients with Asymptomatic Popliteal Artery Calcification on Plain X-ray Adam Podet, MS; Julia Volaufova, phD,;
Incidence of Abnormal Ankle-Brachial Index in Diabetic Patients Asymptomatic of Arteriosclerotic Vascular disease Brintha Vasagar, MD, MPH, Katee Castleman,
TAHAR EL KANDOUSSI, SARA ECHERKI, NAWAL DOGHMI, MOHAMED CHERTI. SEcurite de l’Echocardiographie de stress : plutôt l’effort. Cardiology B Department, Ibn.
Purpose of Epi Studies Discover factors associated with diseases, physical conditions and behaviors Identify the causal factors Show the efficacy of intervening.
Peripheral Artery Disease (PAD)
1 Cross-sectional studies Dr Hardeep Kaur Associate Professor University College of Nursing BFUHS.
Management of Hypertension according to JNC 7
CROSS SECTIONAL STUDIES
- Higher SBP visit-to-visit variability (SBV) has been associated
METHODS SECTION OF A RESEARCH PROPOSAL
A Search For Better Health Topic 11: Epidemiology
EFFECT OF EDUCTION OF DIABETES ON CONTROL OF BP, B
Evaluating Sepsis Guidelines and Patient Outcomes
CURRENT TREND OF DIABETIC FOOT SURGERY IN GENERAL HOSPITAL OF KSA: ARE WE DOING ENOUGH TO AVOID AMPUTATIONS? Dr. Anthony Morgan, Dr. Adel Mohammad bin.
SPIRE Program: Studies of PCSK9 Inhibition and the Reduction of Vascular Events Unanticipated attenuation of LDL-c lowering response to humanized PCSK9.
Peripheral Arterial Disease
Prashant Kaul, MD, FSCAI Piedmont Heart Institute, Atlanta, GA
Rhematoid Rthritis Respiratory disorders
The Walking Impairment Questionnaire stair-climbing score predicts mortality in men and women with peripheral arterial disease  Atul Jain, MD, Kiang Liu,
PREDICTORS OF OUTCOME AMONG PATIENTS WITH TRAUMATIC BRAIN INJURY AT MOI TEACHING AND REFERRAL HOSPITAL: ELDORET, KENYA   Judy C. Rotich.
CROSS SECTIONAL STUDIES
SPIRE Program: Studies of PCSK9 Inhibition and the Reduction of Vascular Events Unanticipated attenuation of LDL-c lowering response to humanized PCSK9.
Presentation transcript:

Peripheral Arterial Disease Patients’ awareness of smoking as a risk factor Class 5, 1 st year 2009/2010 Adviser: Sérgio Sampaio

McDermott MM. Cleve Clin J Med Remes L, et al Gutacker N, et al Zanati SG, et al. Clinics INTRODUCTION: BACKGROUND Narrowing and hardening of arteries Decreased blood flowPAD Difficulty in walking, rest pain, ulceration, lower extremity amputation, death.

Risk Factors Hypertension Hypercholesterolemia Diabetes Smoking Selvin E. et al. Circulation Criqui MH. Vasc Med

Awareness of smoking as a risk factor Hirsch AT et al. Circulation

Justification We decided to evaluate the awareness of smoking as a risk factor because: People, most of the times, cannot control the expression of diabetes, but it is their choice to smoke or not to; There is a low community consciousness of this risk factor.

Justification It will be important to know the awareness of the Portuguese PAD patients to this modifying risk factor, because that way it will be easier to define strategies to improve the communication and to try to make people change their smoking habits.

Research Question How aware are patients with PAD regarding smoking as a major risk factor?

Aims 1. Quantify how frequently patients with PAD know about smoking as a cause and a prognostic of their condition. 2. Determine when and by whom were they warned about this fact. 3. Find out whether people in this state have changed or not their smoking habits due to the provided information. (If they have) Find out if the severity of the disease altered.

Participants and Methods Our target population are Portuguese patients suffering from PAD who are admitted in a hospital. Our inclusion criterion is the patients with PAD being admitted in the Vascular Surgery Department of Hospital de S. João. Our exclusion criteria are: Patients unable to consciously communicate; Patients who do not agree to get involved in this study.

Participants and Methods

Study design Analytic retrospective cohort: patients who were informed of tobacco as a risk factor with patients who were not (cohort) events that happened in the past (retrospective): try to establish the relations among them (analytic) Present PastFuture Informed Not Informed

Data collecting methods Questionnaires were done to patients suffering from PAD, who were admitted in the Vascular Surgery Department of Hospital de São João.

Sample Exclusion criterion: Patients unable to consciously communicate.

Variables description Personal data of PAD patients Diabetes; Hypertension; Hypercholesterolemia; State of the disease at the time of the diagnosis, according to Lerishe-Fontaine classification; Current state of the disease; Date of PAD diagnosis; Smoking habits;

Variables description PAD risk factors awareness Awareness of: Diabetes; Hypercholesterolemia; Hypertension; Smoking; Knowledge sources; If the information was given by a doctor, another variable we decided to put was the specialty of the doctor. Time of risk factors awareness.

Variables description Behaviour changes after awareness of PAD risk factors: Change of smoking habits; Way of change; Number of attempts, if the interviewed patient tried to quit smoking without success.

Statistical analysis/Expected results Scholar degree and the awareness of the risk factors; Time of risk factors awareness and date of PAD diagnosis; Change of smoking habits (type of change) and state of the disease after that behaviour change (evolution of the disease).

Sample description

Mean=64,71

Sample description

Results Hirsch AT et al. Circulation

Results

Observations After 20 days, we have a small sample (N=28). Therefore, the results we achieved were not statiscally significant and there is no variability among some data. We were not able to relate some important variables, such as Change of smoking habits (type of change) and State of the disease after that behaviour change (evolution of the disease).